Lipocine  logo
Lipocine LPCN
€ 1.34 -3.29%
report update icon

Quartalsbericht 2026-Q3
hinzugefügt 05.11.2026

Lipocine ROCE | LPCN

ROCE Jährlich Lipocine

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-71.64 -5.5 -88.03 -33.79 6.71 -95.88 -87.8 -69.23 -28.46 -73.75 -43.78 -77.7 -23.83 72.43 -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
72.43 -95.88 -44.3

ROCE Vierteljährlich Lipocine

2026-Q3 2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-51.4 -71.06 -72.04 -66.07 -41.33 -31.32 -32.81 -8.47 -28.56 -46.09 -44.37 -71.34 -65.75 -42.11 -37.02 -30.61 3.81 1.05 1.97 2.18 -50.68 -63.34 -77.48 -97.74 -95.62 -97.13 -97.19 -86.74 -82.66 -70.08 -62.17 -55.85 -64.93 -72.99 -83.31 -92.66 -75.79 -68.37 -66.3 -73.75 -73.34 -74.62 -60.48 -45.84 -50.28 -62.96 -67.79 -55.25 -65.09 -59.45 -142.84 -237.61 -244.19 -663.1 -510.59 -16.42 -428.88 - 42.52 - - - -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
42.52 -663.1 -87.63

ROCE anderer Aktien in der Pharmaeinzelhändler

Name ROCE Preis % 24h Marktkapitalisierung Land
Catalyst Biosciences Catalyst Biosciences
CBIO
10.83 $ 13.01 0.74 % $ 1.16 B usaUSA
ARCA biopharma ARCA biopharma
ABIO
-25.79 - 1052.0 % $ 415 M usaUSA
ADiTx Therapeutics ADiTx Therapeutics
ADTX
-328.78 - - $ 374 usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
-76.42 - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
-709.03 - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
-29.14 - - $ 1.01 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
-80.33 - 1.93 % $ 17.4 M usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
-281.63 - 10.36 % $ 9.8 M usaUSA
AlloVir AlloVir
ALVR
-41.2 - 4.14 % $ 49.1 M usaUSA
Apellis Pharmaceuticals Apellis Pharmaceuticals
APLS
7.37 - - $ 5.18 B usaUSA
Athira Pharma Athira Pharma
ATHA
-229.05 - - $ 269 M usaUSA
AVROBIO AVROBIO
AVRO
-33.43 - 1083.1 % $ 745 M usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
16.47 - - $ 96.9 B britainBritain
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
99.68 - -2.5 % $ 5.88 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
7.03 - 0.49 % $ 251 B cayman-islandsCayman-islands
EyePoint Pharmaceuticals EyePoint Pharmaceuticals
EYPT
-74.45 $ 0.23 -12.11 % $ 16.8 K usaUSA
Bio-Path Holdings Bio-Path Holdings
BPTH
-2039.46 - - $ 100 K usaUSA
Cara Therapeutics Cara Therapeutics
CARA
-127.18 - -3.03 % $ 260 M usaUSA
ChromaDex Corporation ChromaDex Corporation
CDXC
18.82 - -0.88 % $ 598 M usaUSA
Caladrius Biosciences Caladrius Biosciences
CLBS
-121.99 - -16.75 % $ 25.8 M usaUSA
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCC
-5.84 - -5.98 % $ 34.1 M usaUSA
Diffusion Pharmaceuticals Diffusion Pharmaceuticals
DFFN
-155.27 - 11.68 % $ 8.97 M usaUSA
Eloxx Pharmaceuticals Eloxx Pharmaceuticals
ELOX
50.04 - -5.68 % $ 8.28 M usaUSA
Enochian Biosciences Enochian Biosciences
ENOB
96.98 - - $ 40.5 M usaUSA
Esperion Therapeutics Esperion Therapeutics
ESPR
-19.96 - - $ 661 M usaUSA
Evofem Biosciences Evofem Biosciences
EVFM
-4.86 - 7.55 % $ 38.1 M usaUSA
Eyenovia Eyenovia
EYEN
-95.23 - 49.81 % $ 13.2 M usaUSA
FibroGen FibroGen
FGEN
-82.19 - - $ 889 M usaUSA
Homology Medicines Homology Medicines
FIXX
33.52 - 0.77 % $ 53.4 M usaUSA
Amicus Therapeutics Amicus Therapeutics
FOLD
11.96 - - $ 4.47 B usaUSA
Frequency Therapeutics Frequency Therapeutics
FREQ
-119.97 - - $ 528 M usaUSA
Galecto Galecto
GLTO
-87.69 - - $ 762 M danmarkDanmark
GlycoMimetics GlycoMimetics
GLYC
-74.74 - 9357.83 % $ 1.01 B usaUSA
Graybug Vision Graybug Vision
GRAY
-235.71 - -11.23 % $ 9.65 M usaUSA
Galera Therapeutics Galera Therapeutics
GRTX
-63.97 - -32.59 % $ 7.61 M usaUSA
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
-44.94 - 1.35 % $ 17.8 M chinaChina
Novavax Novavax
NVAX
63.19 $ 7.47 -3.24 % $ 1.21 B usaUSA
Hepion Pharmaceuticals Hepion Pharmaceuticals
HEPA
-150.28 - -18.79 % $ 39.3 K usaUSA
Hoth Therapeutics Hoth Therapeutics
HOTH
-200.97 - - $ 18.8 M usaUSA
IMARA IMARA
IMRA
-26.04 - 15.96 % $ 663 M usaUSA
KalVista Pharmaceuticals KalVista Pharmaceuticals
KALV
-104.22 - - $ 1.45 B britainBritain
KemPharm KemPharm
KMPH
-25.64 - -0.34 % $ 200 M usaUSA
Kezar Life Sciences Kezar Life Sciences
KZR
-84.35 - - $ 53.3 M usaUSA
Lixte Biotechnology Holdings Lixte Biotechnology Holdings
LIXT
-50.56 - - $ 63.4 M usaUSA
Magenta Therapeutics Magenta Therapeutics
MGTA
-35.57 - -7.74 % $ 41.6 M usaUSA
NovaBay Pharmaceuticals NovaBay Pharmaceuticals
NBY
-111.88 - - $ 11.3 M usaUSA
NeuroBo Pharmaceuticals NeuroBo Pharmaceuticals
NRBO
-250.37 - 0.43 % $ 12 M usaUSA
OncoCyte Corporation OncoCyte Corporation
OCX
-373.69 - 17.22 % $ 355 K usaUSA
Onconova Therapeutics Onconova Therapeutics
ONTX
3379.02 - -0.47 % $ 21 M usaUSA
Opthea Limited Opthea Limited
OPT
77.47 - - $ 1.2 B australiaAustralia